Press Releases
9 July 2019
FLINT, Mich., July 9, 2019 /PRNewswire/ -- XLerateHealth (XLH), an award-winning Louisville-based healthcare accelerator, today announced the selection of six startup companies to join the first bootcamp cohort of its accelerator in Flint, MI. XLH opened its Michigan location in
Read more...DENVER, July 9, 2019 /PRNewswire/ -- More than 50 doctors across the U.S. signed an open letter to the USDA calling on the organization to overhaul the U.S. Dietary Guidelines and ensure that recommendations are for all Americans. The letter ran in both the New York Times and Washington Post today.
Read more...WALTHAM, Mass., July 9, 2019 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the leading provider of kidney care products and services, announces a major strategi
Read more...9 July 2019
EMERYVILLE, Calif., and CHICAGO, July 9, 2019 /PRNewswire/ -- BRG (Berkeley Research Group) and Prism Healthcare Partners today closed a transaction through which BRG has acquired equity ownership of Prism. The combined group, BRG | Prism Healthcare, becomes one of the largest healthcare performance improvement consulting firms, with a na
Read more...LOS ANGELES, July 9, 2019 /PRNewswire/ -- Theragun, the preeminent name in percussive massage therapy, officially announced today its multi-year partnership with
Read more...BALTIMORE, July 9, 2019 /PRNewswire/ -- Today, Senior Helpers®, the nation's premier provider of in-home senior care, announced the appointment of Dr.
Read more...SAN DIEGO, July 9, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company, today announced the initiation of patient enrollment of its Phase 1b/2 study of onvansertib in combination with FOLFIRI and Avastin® (bevacizumab) for se
Read more...SAN DIEGO, July 9, 2019 /PRNewswire/ -- Dermata Therapeutics, LLC, today announces positive results from a Phase 1 POC clinical trial of DMT410 (DMT310 + botulinum toxin (BTX)) for the treatment of primary axillary hyperhidrosis. These results provide evidence of Dermata's newly developed combination regimen, DMT400, a mechanism for topically delivering biologics into th
Read more...ANN ARBOR, Mich., July 9, 2019 /PRNewswire/ -- Otava, a global leader in secure cloud services for enterprise and channel partners, has been chosen by
Read more...NEW YORK, July 9, 2019 /PRNewswire/ -- Historically, pregnancy in patients with systemic lupus erythematosus (SLE) was considered so risky that physicians counseled women to avoid becoming pregnant and recommended that women carrying a child terminate their pregnancy. Now, a new study published July 8 in the Annals of Internal Medici
Read more...